Researchers zero in on therapeutic target for aggressive uterine cancer
A common mutation in a rare cancer subtype leads researchers to an already-approved drug that shows promise against uterine serous carcinoma.
December 17, 2021 10:00 AM
Staci L. Vernick
Staci Vernick is a contributing health and science writer. With expertise in healthcare, medical and science communications and a passion for evocative storytelling, Staci has directed communications for academic medical centers and biomedical research organizations, including Johns Hopkins Children’s, The Wistar Institute and the American Association for Cancer Research. A former journalist, she has written on topics ranging from children’s health to cancer biology to health policy.
Gene Discovery Shows Effects of Impaired Protein Synthesis
Researchers identify genetic variants that lead to a severe developmental syndrome. The findings could mean better screening and diagnosis for patients with inherited syndromes.
May 02, 2019 7:00 AM
A New Clue in the Mystery of ALS, Frontotemporal Dementia
Michigan Medicine researchers identify a potential therapeutic target for neurodegenerative conditions using animal models.
April 23, 2019 11:00 AM
Biomarker Holds Promise in COPD Treatment
A team led by U-M researchers discovered that a noninvasive imaging biomarker can identify small airway damage in COPD patients.
April 02, 2019 7:00 AM
